logo
Select company
Select metric
$ -146.58MFree Cash Flow
VS
Market
7
Sector
10
Industry
16
History
27
$ 3.29Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - FCF Historical data
DateCapital ExpenditureFree Cash FlowNet Cash Flow - Operations
6/30/2025$ 32.16M$ -146.58M$ -114.42M
3/31/2025$ 29.68M$ -150.98M$ -121.3M
12/31/2024$ 29.51M$ -155.86M$ -126.35M
9/30/2024$ 5.57M$ -133.14M$ -127.56M
6/30/2024$ 31.11M$ -153.21M$ -122.1M
3/31/2024$ 34.17M$ -132.89M$ -98.72M
12/31/2023$ 34.2M$ -124.27M$ -90.07M
9/30/2023$ 32.93M$ -113.38M$ -80.45M
6/30/2023$ 5.31M$ 459.64M$ 464.94M
3/31/2023$ 1.61M$ -89.23M$ -87.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) FCF stands at $ -1.21M.
  • Over the past 5 years, PROKIDNEY CORP's average FCF has been $ -68.34M.
  • The median FCF for PROKIDNEY CORP during this period was $ -128.58M
  • PROKIDNEY CORP reached its highest FCF over the past 5 years at $ 459.64M.
  • The lowest FCF recorded by PROKIDNEY CORP in the same timeframe $ -155.86M

PROKIDNEY CORP's FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Benchmarks
CompanyFCF
SEPN : SEPTERNA INC $ -83.03MMREO : MEREO BIOPHARMA GROUP PLC $ -32.94MABEO : ABEONA THERAPEUTICS INC $ -71.29MCRDF : CARDIFF ONCOLOGY INC $ -41.87MAVTX : AVALO THERAPEUTICS INC $ -47.42MBBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC $ -97.71MCOYA : COYA THERAPEUTICS INC $ -16.47MMNMD : MIND MEDICINE (MINDMED) INC $ -101.56MSANA : SANA BIOTECHNOLOGY INC $ -184.66MERNA : ERNEXA THERAPEUTICS INC $ -14.45M

Definition of Free Cash Flow

[Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
CF - Operations - CapEx
(=) FCF
FCF for PROKIDNEY CORP is calculated as follows: CF - Operations [ $ -1.21M ] - CapEx [ $ 0 ]
(=) FCF [ $ -1.21M ]

PROK - Free Cash Flow, Last 5 years

$ -155.86M

Minimum

Dec 31, 2024

$ 459.64M

Maximum

Jun 30, 2023

$ -68.34M

Average

$ -128.58M

Median

FCF Benchmark Analysis

The chart above depicts the distribution of FCF for companies in the Total Stock Market. The average FCF of the companies is $ 28.76M with a standard deviation of $ 117.98M.
The following table provides additional summary stats:
FCF in the Market:
filtered constituents3.3K
min$ -356.66M
max$ 390M
average$ 28.76M
median$ 461K
std$ 117.98M